As Vice President, Head of Research and Development Quality and Compliance at Alexion, Coleen leads the establishment of a quality management system for R&D to assure the highest standards of Quality in ultra-rare diseases. Most recently, she has been focused on implementing sustainable processes and controls for Alexion’s accelerated growth while developing a culture of quality. She has a BS from the University of Pittsburgh and an MBA from MIT.